Aromatase inhibitors for subfertile women with polycystic ovary syndrome

Abstract excerpt

BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common cause of infrequent periods (oligomenorrhoea) and absence of periods (amenorrhoea). It affects about 4% to 8% of women worldwide and often leads to anovulatory subfertility. Aromatase inhibitors (AIs) are a novel class of drugs that were introduced for ovulation induction in 2001. Over the last ten years clinical trials have reached differing...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Menopause: Health Impacts and Treatments
• Share to Ovarian function and disorders
• Share to Reproductive Health and Technologies